Clinical Trials on Carcinoma, Neuroendocrine in Germany

Total 1719 results

University Hospital, Bonn
Mundipharma Research GmbH & Co KG

Terminated

A Clinical Trial to Assess the Safety & Efficacy of the Treatment of Patients With Metastasis From Malignant Melanoma - Treatment Consists of the Substances Lomustine (Capsules) & Cytarabine (Injected Into an Area Near the Spinal Cord), Accompanied by Radiotherapy of the Brain

Leptomeningeal Metastasis From Malignant Melanoma

Germany
University Hospital Tuebingen

Recruiting

Treatment of Cervical Intraepithelial Neoplasia (CIN) Grade III With Non-invasive Physical Plasma (ZGynO_CINIII)

Cervical Intraepithelial Neoplasia III

Germany
JSehouli

Completed

Efficacy and Safety Study of Sorafenib With Topotecan in Patients With Platinum-resistant Recurrent Ovarian Cancer (TRIAS 2009)

Ovarian Cancer

Germany
North Eastern German Society of Gynaecological...

Completed

Preference Study With Elderly Patients Recurrent Ovarian Cancer

Ovarian Cancer

Germany
Bristol-Myers Squibb

Recruiting

An Observational Study to Evaluate Neoadjuvant Nivolumab (OPDIVO®) in Combination With Platinum-Based Chemotherapy in Non-Metastatic Non-Small Cell Lung Cancer Participants in Germany (NENI)

Resectable Non-small Cell Lung Cancer

Germany
Astellas Pharma Inc

Completed

LUCY: A Study for the Treatment of Non-Small Cell Lung Cancer (NSCLC) in Patients Previously Treated With Chemotherapy

Lung Cancer | Carcinoma, Non-Small Cell Lung | Cancer of Lung | Non-Small Cell Lung Carcinoma | Cancer of the Lung

Germany, Czech Republic, Netherlands
EMD Serono

Terminated

Sym004 in Subjects With Stage IV Non-small Cell Lung Cancer

Carcinoma, Non-Small-Cell Lung

United States, Germany
Aktion Bronchialkarzinom e.V.
Boehringer Ingelheim

Completed

An Dose Escalation Trial of Oral BIBF 1120 in Combination With Intravenous Vinorelbine in Elderly Patients With Advanced Non Small Lung Cell Cancer - Stage IV (VENUS-1) (VENUS-1)

Carcinoma, Non-Small-Cell Lung

Germany
National Cancer Institute, Naples
Immatics Biotechnologies GmbH; CureVac; European Commission -FP7-Health-2013-Innovation-1

Completed

IMA970A Plus CV8102 in Very Early, Early and Intermediate Stage Hepatocellular Carcinoma Patients

Hepatocellular Carcinoma

Belgium, Germany, Italy, Spain, United Kingdom
Heinrich-Heine University, Duesseldorf

Terminated

TACE and Sorafenib for Advanced Hepatocellular Carcinoma (HCC) (SOCRATES)

Hepatocellular Carcinoma

Germany
Novartis Pharmaceuticals

Completed

Effect of Zoledronic Acid in Patients With Renal Cell Cancer and Bone Metastasis

Neoplasm Metastasis | Renal Cell Cancer

Germany
Charite University, Berlin, Germany
ribosepharm GmbH

Unknown

Study to Determine the Efficacy of Bendamustin in Patients With Recurrent Small Cell Lung Cancer (SCLC)

Recurrent Small Cell Lung Cancer

Germany
Institut für Klinische Krebsforschung IKF GmbH...
Merck Sharp & Dohme LLC; Medizinische Hochschule Hannover, Germany, Prof. Dr...

Active, not recruiting

Pembrolizumab and Lenvatinib in Patients With Advanced HCC Who Are Refractory to Atezolizumab and Bevacizumab/ IO-based Therapy

Hepatocellular Carcinoma

Germany
University of Leipzig

Recruiting

Postoperative aRCH With Cisplatin Versus aRCH With Cisplatin and Pembrolizumab in Locally Advanced Head and Neck Squamous Cell Carcinoma

HNSCC

Germany
Ludwig-Maximilians - University of Munich

Completed

Fear of Cancer Recurrence in Genitourinary Cancer

Prostate Cancer | Urothelial Carcinoma | Renal Cell Cancer | Fear of Cancer Recurrence | Testicle Cancer

Germany
Philogen S.p.A.
Eudax S.r.l.

Terminated

Clinical Study Phase II of L19IL2 in Combination With Dacarbazine in Patients With Metastatic Melanoma

Metastatic Melanoma

Switzerland, Italy, Austria, Germany
EMD Serono

Terminated

Tecemotide Following Concurrent Chemo-radiotherapy for Non-small Cell Lung Cancer (START2)

Carcinoma, Non-Small-Cell Lung

United States, Germany
Association of Urologic Oncology (AUO)
Eli Lilly and Company

Unknown

Adjuvant Versus Progression-Triggered Gemcitabine Monotherapy for Locally Advanced Bladder Cancer

Carcinoma, Transitional Cell | Bladder Cancer

Germany
Neovii Biotech

Completed

CASIMAS: Catumaxomab Safety Phase IIIb Study With Intraperitoneal Infusion in Patients With Malignant Ascites Due to Epithelial Cancers (CASIMAS)

Neoplasms | Carcinoma | Cancer | Malignant Ascites

France, Germany, Italy, Spain
AIO-Studien-gGmbH
Bristol-Myers Squibb; Eli Lilly and Company; Merck Sharp & Dohme LLC; Pfizer; Gilead... and other collaborators

Recruiting

Clinical Research Platform Into Molecular Testing, Treatment and Outcome of (Non-)Small Cell Lung Carcinoma Patients (CRISP)

Small-cell Lung Cancer | Non-small Cell Lung Cancer Metastatic | Non-small Cell Lung Cancer Stage I | Metastatic Non-small Cell Lung Cancer (NSCLC) | Non Small Cell Lung Cancer Stage III | Non-small Cell Lung Cancer Stage II

Germany
Universitätsklinikum Hamburg-Eppendorf

Recruiting

Lymph Node Mapping Via Flourescent Dye in Colon Cancer

Colon Carcinoma | Lymph Node Metastases

Germany
Pierre Fabre Medicament
Pierre Fabre Pharma GmbH

Completed

Oral Chemotherapy And Platinum With Radiotherapy Followed Or Not By Consolidation With The Same Chemotherapy In Locally Advanced Non Small Cell Lung Cancer

NSCLC

Germany
Boehringer Ingelheim

Completed

Nintedanib and Weekly Docetaxel in Lung Adenocarcinoma

Carcinoma, Non-Small-Cell Lung

France, Germany
North Eastern German Society of Gynaecological...

Completed

Topotecan Vs. Topotecan + Etoposide Vs.Topotecan + Gemcitabine in Ovarian Cancer Therapy

Ovarian Cancer

Germany
Krankenhaus Nordwest

Completed

Prospective Study With FLOT in Patients With Locally Advanced, Limited Metastatic or Extensive Metastatic Adenocarcinoma of the Stomach or Esophagogastric Junction (FLOT3)

Gastric Cancer | Adenocarcinoma of the Esophagogastric Junction

Germany
University of Erlangen-Nürnberg Medical School

Unknown

Effects of Deep Regional Hyperthermia in Patients With Anal Carcinoma Treated by Standard Radiochemotherapy (HYCAN)

Anal Carcinoma

Germany
JSehouli
GlaxoSmithKline

Unknown

Pazopanib and Weekly Topotecan in Patients Recurrent Ovarian Cancer (TOPAZ)

Ovarian Cancer

Germany
ITM Solucin GmbH

Recruiting

Lutetium 177Lu-Edotreotide Versus Best Standard of Care in Well-differentiated Aggressive Grade-2 and Grade-3 GastroEnteroPancreatic NeuroEndocrine Tumors (GEP-NETs) - COMPOSE (COMPOSE)

Neuroendocrine Tumors

United States, United Kingdom, Australia, France, Italy, Netherlands, Spain, Germany, Sweden, India
University of Cologne

Withdrawn

Immunogenicity and Safety of Pneumococcal Vaccination in Patients Treated With Immune Checkpoint Inhibitors (SPICE)

Melanoma | Non Small Cell Lung Cancer

Germany
Hannover Medical School

Terminated

Taxotere-Enoxaparin-(ENOXA)-Study

Non-small Cell Lung Cancer

Germany
Johannes Gutenberg University Mainz

Completed

Chromoscopic Guided Endomicroscpy to Diagnose Colitis Associated Dysplasia

Cancer | Ulcerative Colitis | Intraepithelial Neoplasia

Germany
Technische Universität Dresden
German Cancer Research Center; National Center for Tumor Diseases, Heidelberg; Radiation Oncology Working Group of the German Cancer Society and other collaborators

Recruiting

De-escalation of Adjuvant Radio (Chemo) Therapy for HPV-positive Head-neck Squamous Cell Carcinomas (DELPHI)

Head-and-neck Squamous Cell Carcinoma

Germany
MedInnovation GmbH
Helios Klinikum Berlin-Buch

Terminated

Validation of MMS Test for Cancer Monitoring (MMS-TM)

Melanoma | Sarcoma | Stomach Cancer | Colo-rectal Cancer

Germany
iOMEDICO AG

Recruiting

Registry Platform Ovarian and Endometrial Cancer (SMARAGD)

Carcinoma | Ovarian Cancer | Endometrial Neoplasms | Endometrial Cancer | Ovary Neoplasm | Neoplasm, Ovarian | Carcinoma, Ovarian

Germany
German Breast Group
Roche Pharma AG; Amgen; Teva Pharmaceuticals USA; Vifor Pharma

Completed

A Phase III Trial Comparing Two Dose-dense, Dose-intensified Approaches (ETC and PM(Cb)) for Neoadjuvant Treatment of Patients With High-risk Early Breast Cancer (GeparOcto)

Inflammatory Breast Cancer | HER2 Positive Breast Cancer | Tubular Breast Cancer Stage II | Mucinous Breast Cancer Stage II | Breast Cancer Female NOS | Invasive Ductal Breast Cancer | Tubular Breast Cancer Stage III

Germany
Federation Francophone de Cancerologie Digestive

Terminated

A Study Evaluating Lanreotide as Maintenance Therapy in Patients With Non-Resectable Duodeno-Pancreatic Neuroendocrine Tumors (REMINET) (REMINET)

Metastatic/Locally Advanced, Non-resectable, Duodeno-pancreatic Neuroendocrine Tumours

France, Belgium, Germany, United Kingdom
Technische Universität Dresden

Not yet recruiting

Individualized Radiation Dose Prescription in HNSCC Based on F-MISO-PET Hypoxia-Imaging (INDIRA-MISO)

Head and Neck Squamous Cell Carcinoma

Germany
Central European Society for Anticancer Drug Research

Completed

Sequential Therapy in Metastatic Renal Cell Carinoma (BERAT)

Metastatic Renal Cell Carcinoma

Germany
Universitätsklinikum Hamburg-Eppendorf

Recruiting

Short-term Psychodynamic Psychotherapy in Serious Physical Illness (ORPHYS)

Carcinoma | Palliative Care | Malignant Neoplasm

Germany
Camurus AB

Active, not recruiting

A Trial to Assess Efficacy and Safety of Octreotide Subcutaneous Depot in Patients With GEP-NET (SORENTO)

Gastro-enteropancreatic Neuroendocrine Tumor

United States, Belgium, Spain, Netherlands, France, Germany, Israel, Italy, Canada, Australia, Romania, Hungary
University Medical Center Goettingen

Recruiting

Pancreatic Ductal Adenocarcinoma - Microbiome as Predictor of Subtypes (PDA-MAPS)

Pancreatic Cancer

Germany
Heidelberg University
Merck KGaA, Darmstadt, Germany

Unknown

Paclitaxel/Carboplatin With or Without Cetuximab in CUP (PACET-CUP)

Carcinoma | Neoplasms, Unknown Primary

Germany
P. C. Thuss-Patience

Recruiting

Avelumab + Paclitaxel/ Ramucirumab (RAP) as Second Line Treatment in Gastro-esophageal Adenocarcinoma (AIO-STO-0218)

Gastroesophageal Junction Adenocarcinoma | Adenocarcinoma of the Stomach

Germany
Charite University, Berlin, Germany

Withdrawn

Perioperative Assessment of Right Ventricular Function and Venous Return in Patients With Epithelial Ovarian Cancer Undergoing Cytoreductive Surgery (Gyn Right) - Pilot Study

Right Ventricular Function and Venous Return

Germany
Gerhard Treiber
Crolll Gmbh; Janssen Diagnostics, LLC; Estimate, GmbH

Completed

Antiangiogenic Treatment of Hepatocellular Cancer With Bevacizumab and RAD001

Hepatocellular Carcinoma

Germany
ViMREX GmbH
Frankfurter Institut für Klinische Krebsforschung IKF GmbH am Krankenhaus...

Active, not recruiting

Clinical Trial With Local Decitabine Treatment of HPV-Induced VIN Grade 2/3 (DelVIN) (DelVIN)

Vulvar Intraepithelial Neoplasia Grade 2 | Vulvar Intraepithelial Neoplasia Grade 3

Germany
Boehringer Ingelheim

Completed

Efficacy and Safety of BI 2536 in Advanced or Metastatic Non Small Cell Lung Cancer

Carcinoma, Non-Small-Cell Lung

Germany
Onkovis GmbH
AKP Freiburg GmbH

Completed

A Non Interventional Study With Irinotecan Onkovis (Irinotecan) Utilized for the Treatment of Cancer

Carcinoma

Germany
European Organisation for Research and Treatment...

Completed

ISIS 3521 in Treating Patients With Advanced, Unresectable, or Metastatic Non-small Cell Lung Cancer or Unresectable or Metastatic Melanoma

Lung Cancer | Melanoma (Skin)

France, Netherlands, Norway, Belgium, Switzerland, United Kingdom, Germany, Denmark, Austria
Technische Universität Dresden

Recruiting

Re-irradiation of Recurrent Head and Neck Cancer (ReKo)

Head-and-neck Carcinoma

Germany

Clinical Trials on Carcinoma, Neuroendocrine in Germany

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in United Arab Emirates

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations